news roundup

NovaQuest Private Equity Acquires Majority Interest in Clinical Ink

Clinical Ink, the pioneering provider of eSource and next-generation ePRO/eCOA solutions for clinical development, announced that the private equity team at NovaQuest has acquired a majority of the outstanding shares of the company from existing investors and provided a substantial infusion of additional growth capital.

WCG Clinical Services Division Opens Office in Japan

WIRB-Copernicus Group (WCG) Clinical Services Division, a provider of solutions that improve the quality and efficiency of clinical research, announced the opening of the company's new office in Tokyo, Japan which will allow them to provide global clinical trials.

Saama Technologies and ICON Partner to Unlock the Value of RWE

Saama Technologies, a clinical and health data analytics company, and ICON plc, a global provider of drug development and commercialization solutions and services, have partnered to accelerate the use of Real World Evidence across the product lifecycle and drive mission critical decisions for medical affairs, reimbursement, and commercialization functions.

"Right-to-Try" Scope Expanding to Europe?

Peter O'Donnell explores potential parallels of the U.S. "right-to-try" debate in Europe.

Articles

EMA's Demands for Plain-Language Summaries for Clinical Trial Results that can be Understood by Anyone Could Create new Challenges for Sponsors

From 2019, to comply with requirements for greater transparency around clinical research as part of the EU Clinical Trials Regulation 536/2014, life sciences firms will be expected to prepare plain-language summaries for all Phase I through IV interventional trials, which can be understood by patients, the general public, and experts.

Setting up a Central Lab for a Clinical Trial

When less is more. Using three referral labs vs. one central lab.

Ask the editor

Lisa Henderson
Editor in Chief
Lisa.Henderson@ubm.com